Goro Sashida
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 2%
Papers in
- Hematology 59
- Acute Myeloid Leukemia Research 51
- Chronic Myeloid Leukemia Treatments 14
- Hematopoietic Stem Cell Transplantation 10
-
- Epigenetics and DNA Methylation 22
- Co-authors
- Kazuma Ohyashiki (31 shared papers)Junko H. Ohyashiki (18 shared papers)Tetsuzo Tauchi (13 shared papers)Atsushi Iwama (29 shared papers)Masahiko Sumi (7 shared papers)Akihiro Nakajima (10 shared papers)Kazuo Shin‐ya (3 shared papers)Makiko Mochizuki‐Kashio (12 shared papers)
- Journals
- Blood (16 papers)International Journal of Hematology (8 papers)Oncogene (5 papers)Leukemia (5 papers)Nature Communications (4 papers)
- Partner nations
- JapanUnited StatesSingapore
In The Last Decade
Goro Sashida
87 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 89
- Hematology 1.1k
- Genetics 392
- Molecular Biology 1.9k
- Cancer Research 245
- Physiology 405
Countries citing papers authored by Goro Sashida
This map shows the geographic impact of Goro Sashida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Goro Sashida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Goro Sashida more than expected).
Fields of papers citing papers by Goro Sashida
This network shows the impact of papers produced by Goro Sashida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Goro Sashida. The network helps show where Goro Sashida may publish in the future.
Co-authors
The 25 scholars most cited alongside Goro Sashida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 438 | |
| 2 | 2006 | 194 | |
| 3 | 2003 | 181 | |
| 4 | 2012 | 154 | |
| 5 | 2013 | 140 | |
| 6 | 2014 | 136 | |
| 7 | 2002 | 115 | |
| 8 | 2015 | 107 | |
| 9 | 2003 | 85 | |
| 10 | 2016 | 71 | |
| 11 | 2011 | 60 | |
| 12 | 2009 | 47 | |
| 13 | A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia. | 2004 | 46 |
| 14 | 2002 | 43 | |
| 15 | Inhibition of human telomerase enhances the effect of the tyrosine kinase inhibitor, imatinib, in BCR-ABL-positive leukemia cells. | 2002 | 40 |
| 16 | 2019 | 39 | |
| 17 | 2012 | 38 | |
| 18 | 2016 | 37 | |
| 19 | 2009 | 36 | |
| 20 | 2014 | 35 |
About Goro Sashida
Goro Sashida is a scholar working on Hematology, Molecular Biology, Genetics, Oncology and Physiology, having authored 89 papers that have together received 2.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (51 papers), Epigenetics and DNA Methylation (22 papers), Chronic Myeloid Leukemia Treatments (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers), Hematopoietic Stem Cell Transplantation (10 papers), Telomeres, Telomerase, and Senescence (8 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Immune Cell Function and Interaction (7 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (392 citations), Molecular Biology (1.9k citations), Cancer Research (245 citations) and Physiology (405 citations). Goro Sashida has collaborated with scholars based in Japan, United States and Singapore. Frequent co-authors include Kazuma Ohyashiki, Junko H. Ohyashiki, Tetsuzo Tauchi, Atsushi Iwama, Masahiko Sumi, Akihiro Nakajima, Kazuo Shin‐ya, Makiko Mochizuki‐Kashio, Motohiko Oshima and Stephen D. Nimer. Their work appears in journals such as Blood, International Journal of Hematology, Oncogene, Leukemia and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.